Researchers at The University of Texas MD Anderson Cancer Center have identified a novel strategy to reduce immune-related adverse events...
immunotherapy
Scar-like cells that make up a sizable portion of malignant pancreatic tumors and shield these cancers from immune attack are...
It's not often that a failed clinical trial leads to a scientific breakthrough. When patients in the UK started showing...
Despite the success of immunotherapy in helping many people with cancer, the majority of patients still do not respond to...
In the fight against cancer, the development of efficacious drugs is only half the battle; equally important is how drugs...
Patients with cancers stemming from non-reproductive organs, such as bladder and liver cancer, have striking discrepancies in incidence, progression, response...
Combining a retrospective analysis of clinical records with in-depth laboratory studies, researchers at The University of Texas MD Anderson Cancer...
Colon cancer is one of the most common types of cancer. Particularly in advanced stages of disease, the treatment still...
The U.S. Food and Drug Administration has approved a novel therapy for patients with metastatic or inoperable melanoma, an aggressive...
A study published in the journal Nature Cancer, carried out within the Cancer Programme at the Hospital del Mar Medical...